Titre : Protéines mitochondriales

Protéines mitochondriales : Questions médicales fréquentes

Termes MeSH sélectionnés :

Drug Compounding
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Protéines mitochondriales : Questions médicales les plus fréquentes", "headline": "Protéines mitochondriales : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Protéines mitochondriales : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-12", "dateModified": "2025-04-07", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Protéines mitochondriales" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Protéines", "url": "https://questionsmedicales.fr/mesh/D011506", "about": { "@type": "MedicalCondition", "name": "Protéines", "code": { "@type": "MedicalCode", "code": "D011506", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Aldehyde dehydrogenase, mitochondrial", "alternateName": "Aldehyde Dehydrogenase, Mitochondrial", "url": "https://questionsmedicales.fr/mesh/D000071396", "about": { "@type": "MedicalCondition", "name": "Aldehyde dehydrogenase, mitochondrial", "code": { "@type": "MedicalCode", "code": "D000071396", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.093" } } }, { "@type": "MedicalWebPage", "name": "Mitochondrial creatine kinase", "alternateName": "Creatine Kinase, Mitochondrial Form", "url": "https://questionsmedicales.fr/mesh/D052281", "about": { "@type": "MedicalCondition", "name": "Mitochondrial creatine kinase", "code": { "@type": "MedicalCode", "code": "D052281", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.186" } } }, { "@type": "MedicalWebPage", "name": "DNA Polymerase gamma", "alternateName": "DNA Polymerase gamma", "url": "https://questionsmedicales.fr/mesh/D000074002", "about": { "@type": "MedicalCondition", "name": "DNA Polymerase gamma", "code": { "@type": "MedicalCode", "code": "D000074002", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.280" } } }, { "@type": "MedicalWebPage", "name": "Ferrochelatase", "alternateName": "Ferrochelatase", "url": "https://questionsmedicales.fr/mesh/D005294", "about": { "@type": "MedicalCondition", "name": "Ferrochelatase", "code": { "@type": "MedicalCode", "code": "D005294", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.562" } } }, { "@type": "MedicalWebPage", "name": "Protéines de transport de la membrane mitochondriale", "alternateName": "Mitochondrial Membrane Transport Proteins", "url": "https://questionsmedicales.fr/mesh/D033681", "about": { "@type": "MedicalCondition", "name": "Protéines de transport de la membrane mitochondriale", "code": { "@type": "MedicalCode", "code": "D033681", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.750" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Mitochondrial ADP, ATP Translocases", "alternateName": "Mitochondrial ADP, ATP Translocases", "url": "https://questionsmedicales.fr/mesh/D000226", "about": { "@type": "MedicalCondition", "name": "Mitochondrial ADP, ATP Translocases", "code": { "@type": "MedicalCode", "code": "D000226", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.750.500" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Translocateur-1 de nucléotides adényliques", "alternateName": "Adenine Nucleotide Translocator 1", "url": "https://questionsmedicales.fr/mesh/D033741", "about": { "@type": "MedicalCondition", "name": "Translocateur-1 de nucléotides adényliques", "code": { "@type": "MedicalCode", "code": "D033741", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.750.500.100" } } }, { "@type": "MedicalWebPage", "name": "Translocateur-2 de nucléotides adényliques", "alternateName": "Adenine Nucleotide Translocator 2", "url": "https://questionsmedicales.fr/mesh/D033742", "about": { "@type": "MedicalCondition", "name": "Translocateur-2 de nucléotides adényliques", "code": { "@type": "MedicalCode", "code": "D033742", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.750.500.200" } } }, { "@type": "MedicalWebPage", "name": "Translocateur-3 de nucléotides adényliques", "alternateName": "Adenine Nucleotide Translocator 3", "url": "https://questionsmedicales.fr/mesh/D033781", "about": { "@type": "MedicalCondition", "name": "Translocateur-3 de nucléotides adényliques", "code": { "@type": "MedicalCode", "code": "D033781", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.750.500.300" } } } ] }, { "@type": "MedicalWebPage", "name": "Translocateur-1 de nucléotides adényliques", "alternateName": "Adenine Nucleotide Translocator 1", "url": "https://questionsmedicales.fr/mesh/D033741", "about": { "@type": "MedicalCondition", "name": "Translocateur-1 de nucléotides adényliques", "code": { "@type": "MedicalCode", "code": "D033741", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.750.500.100" } } }, { "@type": "MedicalWebPage", "name": "Translocateur-2 de nucléotides adényliques", "alternateName": "Adenine Nucleotide Translocator 2", "url": "https://questionsmedicales.fr/mesh/D033742", "about": { "@type": "MedicalCondition", "name": "Translocateur-2 de nucléotides adényliques", "code": { "@type": "MedicalCode", "code": "D033742", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.750.500.200" } } }, { "@type": "MedicalWebPage", "name": "Translocateur-3 de nucléotides adényliques", "alternateName": "Adenine Nucleotide Translocator 3", "url": "https://questionsmedicales.fr/mesh/D033781", "about": { "@type": "MedicalCondition", "name": "Translocateur-3 de nucléotides adényliques", "code": { "@type": "MedicalCode", "code": "D033781", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.750.500.300" } } }, { "@type": "MedicalWebPage", "name": "Pore de transition de perméabilité mitochondriale", "alternateName": "Mitochondrial Permeability Transition Pore", "url": "https://questionsmedicales.fr/mesh/D000083162", "about": { "@type": "MedicalCondition", "name": "Pore de transition de perméabilité mitochondriale", "code": { "@type": "MedicalCode", "code": "D000083162", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.750.563" } } }, { "@type": "MedicalWebPage", "name": "Protéines du complexe d'import des protéines précurseurs mitochondriales", "alternateName": "Mitochondrial Precursor Protein Import Complex Proteins", "url": "https://questionsmedicales.fr/mesh/D000090622", "about": { "@type": "MedicalCondition", "name": "Protéines du complexe d'import des protéines précurseurs mitochondriales", "code": { "@type": "MedicalCode", "code": "D000090622", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.750.594" } } }, { "@type": "MedicalWebPage", "name": "Mitochondrial Proton-Translocating ATPases", "alternateName": "Mitochondrial Proton-Translocating ATPases", "url": "https://questionsmedicales.fr/mesh/D025261", "about": { "@type": "MedicalCondition", "name": "Mitochondrial Proton-Translocating ATPases", "code": { "@type": "MedicalCode", "code": "D025261", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.750.625" } } }, { "@type": "MedicalWebPage", "name": "Protéines de découplage mitochondrial", "alternateName": "Mitochondrial Uncoupling Proteins", "url": "https://questionsmedicales.fr/mesh/D000071245", "about": { "@type": "MedicalCondition", "name": "Protéines de découplage mitochondrial", "code": { "@type": "MedicalCode", "code": "D000071245", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.750.688" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Protéine-1 de découplage", "alternateName": "Uncoupling Protein 1", "url": "https://questionsmedicales.fr/mesh/D000071256", "about": { "@type": "MedicalCondition", "name": "Protéine-1 de découplage", "code": { "@type": "MedicalCode", "code": "D000071256", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.750.688.500" } } }, { "@type": "MedicalWebPage", "name": "Protéine-2 de découplage", "alternateName": "Uncoupling Protein 2", "url": "https://questionsmedicales.fr/mesh/D000071246", "about": { "@type": "MedicalCondition", "name": "Protéine-2 de découplage", "code": { "@type": "MedicalCode", "code": "D000071246", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.750.688.750" } } }, { "@type": "MedicalWebPage", "name": "Protéine-3 de découplage", "alternateName": "Uncoupling Protein 3", "url": "https://questionsmedicales.fr/mesh/D000071247", "about": { "@type": "MedicalCondition", "name": "Protéine-3 de découplage", "code": { "@type": "MedicalCode", "code": "D000071247", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.750.688.875" } } } ] }, { "@type": "MedicalWebPage", "name": "Protéine-1 de découplage", "alternateName": "Uncoupling Protein 1", "url": "https://questionsmedicales.fr/mesh/D000071256", "about": { "@type": "MedicalCondition", "name": "Protéine-1 de découplage", "code": { "@type": "MedicalCode", "code": "D000071256", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.750.688.500" } } }, { "@type": "MedicalWebPage", "name": "Protéine-2 de découplage", "alternateName": "Uncoupling Protein 2", "url": "https://questionsmedicales.fr/mesh/D000071246", "about": { "@type": "MedicalCondition", "name": "Protéine-2 de découplage", "code": { "@type": "MedicalCode", "code": "D000071246", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.750.688.750" } } }, { "@type": "MedicalWebPage", "name": "Protéine-3 de découplage", "alternateName": "Uncoupling Protein 3", "url": "https://questionsmedicales.fr/mesh/D000071247", "about": { "@type": "MedicalCondition", "name": "Protéine-3 de découplage", "code": { "@type": "MedicalCode", "code": "D000071247", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.750.688.875" } } }, { "@type": "MedicalWebPage", "name": "Canal anionique-1 voltage-dépendant", "alternateName": "Voltage-Dependent Anion Channel 1", "url": "https://questionsmedicales.fr/mesh/D050995", "about": { "@type": "MedicalCondition", "name": "Canal anionique-1 voltage-dépendant", "code": { "@type": "MedicalCode", "code": "D050995", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.750.750" } } }, { "@type": "MedicalWebPage", "name": "Canal anionique-2 voltage-dépendant", "alternateName": "Voltage-Dependent Anion Channel 2", "url": "https://questionsmedicales.fr/mesh/D050996", "about": { "@type": "MedicalCondition", "name": "Canal anionique-2 voltage-dépendant", "code": { "@type": "MedicalCode", "code": "D050996", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.750.875" } } } ] }, { "@type": "MedicalWebPage", "name": "Protéine trifonctionnelle mitochondriale", "alternateName": "Mitochondrial Trifunctional Protein", "url": "https://questionsmedicales.fr/mesh/D063991", "about": { "@type": "MedicalCondition", "name": "Protéine trifonctionnelle mitochondriale", "code": { "@type": "MedicalCode", "code": "D063991", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.765" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Sous-unité alpha de la protéine trifonctionnelle mitochondriale", "alternateName": "Mitochondrial Trifunctional Protein, alpha Subunit", "url": "https://questionsmedicales.fr/mesh/D063992", "about": { "@type": "MedicalCondition", "name": "Sous-unité alpha de la protéine trifonctionnelle mitochondriale", "code": { "@type": "MedicalCode", "code": "D063992", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.765.200" } } }, { "@type": "MedicalWebPage", "name": "Sous-unité bêta de la protéine trifonctionnelle mitochondriale", "alternateName": "Mitochondrial Trifunctional Protein, beta Subunit", "url": "https://questionsmedicales.fr/mesh/D063993", "about": { "@type": "MedicalCondition", "name": "Sous-unité bêta de la protéine trifonctionnelle mitochondriale", "code": { "@type": "MedicalCode", "code": "D063993", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.765.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Nucleoside diphosphate kinase D", "alternateName": "Nucleoside Diphosphate Kinase D", "url": "https://questionsmedicales.fr/mesh/D061107", "about": { "@type": "MedicalCondition", "name": "Nucleoside diphosphate kinase D", "code": { "@type": "MedicalCode", "code": "D061107", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.781" } } }, { "@type": "MedicalWebPage", "name": "Peroxiredoxin III", "alternateName": "Peroxiredoxin III", "url": "https://questionsmedicales.fr/mesh/D061105", "about": { "@type": "MedicalCondition", "name": "Peroxiredoxin III", "code": { "@type": "MedicalCode", "code": "D061105", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.812" } } }, { "@type": "MedicalWebPage", "name": "Prohibitines", "alternateName": "Prohibitins", "url": "https://questionsmedicales.fr/mesh/D000091402", "about": { "@type": "MedicalCondition", "name": "Prohibitines", "code": { "@type": "MedicalCode", "code": "D000091402", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.844" } } }, { "@type": "MedicalWebPage", "name": "Sirtuine-3", "alternateName": "Sirtuin 3", "url": "https://questionsmedicales.fr/mesh/D056566", "about": { "@type": "MedicalCondition", "name": "Sirtuine-3", "code": { "@type": "MedicalCode", "code": "D056566", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.875" } } } ], "about": { "@type": "MedicalCondition", "name": "Protéines mitochondriales", "alternateName": "Mitochondrial Proteins", "code": { "@type": "MedicalCode", "code": "D024101", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Thomas Becker", "url": "https://questionsmedicales.fr/author/Thomas%20Becker", "affiliation": { "@type": "Organization", "name": "Institute of Biochemistry und Molecular Biology, ZBMZ, Faculty of Medicine, University of Freiburg, 79104 Freiburg, Germany." } }, { "@type": "Person", "name": "Johannes M Herrmann", "url": "https://questionsmedicales.fr/author/Johannes%20M%20Herrmann", "affiliation": { "@type": "Organization", "name": "Cell Biology, University of Kaiserslautern, Kaiserslautern, Germany. Electronic address: hannes.herrmann@biologie.uni-kl.de." } }, { "@type": "Person", "name": "Timothy E Shutt", "url": "https://questionsmedicales.fr/author/Timothy%20E%20Shutt", "affiliation": { "@type": "Organization", "name": "Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada." } }, { "@type": "Person", "name": "Cole M Haynes", "url": "https://questionsmedicales.fr/author/Cole%20M%20Haynes", "affiliation": { "@type": "Organization", "name": "Molecular, Cell and Cancer Biology, UMass-Chan Medical School, Worcester, MA 01655, USA." } }, { "@type": "Person", "name": "Yang Yang", "url": "https://questionsmedicales.fr/author/Yang%20Yang", "affiliation": { "@type": "Organization", "name": "Stem Cells and Metabolism Research Program, Research Programs Unit, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Compounded medications for cardiovascular use in neonatology: an integrative review.", "datePublished": "2022-09-09", "url": "https://questionsmedicales.fr/article/36102396", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1590/1984-0462/2023/41/2021167" } }, { "@type": "ScholarlyArticle", "name": "Impact of Apparatus and Adapter on In vitro Drug Release of Ophthalmic Semisolid Drug Products.", "datePublished": "2023-09-07", "url": "https://questionsmedicales.fr/article/37679656", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11095-023-03586-x" } }, { "@type": "ScholarlyArticle", "name": "Economic Considerations and Cost-Saving Strategies for Nonsterile Compounding Education.", "datePublished": "2023-07-16", "url": "https://questionsmedicales.fr/article/37454811", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ajpe.2023.100571" } }, { "@type": "ScholarlyArticle", "name": "Advancing algorithmic drug product development: Recommendations for machine learning approaches in drug formulation.", "datePublished": "2023-08-09", "url": "https://questionsmedicales.fr/article/37562550", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ejps.2023.106562" } }, { "@type": "ScholarlyArticle", "name": "Accelerated Predictive Stability Study of a Pediatric Drug Product for a Supplemental New Drug Application.", "datePublished": "2024-06-06", "url": "https://questionsmedicales.fr/article/38844721", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1208/s12249-024-02848-0" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Protéines mitochondriales", "item": "https://questionsmedicales.fr/mesh/D024101" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Protéines mitochondriales - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Protéines mitochondriales", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-05", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Protéines mitochondriales", "description": "Comment diagnostiquer une dysfonction mitochondriale ?\nQuels tests sanguins sont utilisés pour évaluer les protéines mitochondriales ?\nQuels symptômes indiquent une maladie mitochondriale ?\nLes tests génétiques sont-ils fiables pour les maladies mitochondriales ?\nQuel rôle joue l'imagerie dans le diagnostic mitochondrial ?", "url": "https://questionsmedicales.fr/mesh/D024101?mesh_terms=Drug+Compounding&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Protéines mitochondriales", "description": "Quels sont les symptômes courants des maladies mitochondriales ?\nLes troubles cognitifs sont-ils liés aux protéines mitochondriales ?\nComment la myopathie mitochondriale se manifeste-t-elle ?\nLes troubles cardiaques sont-ils fréquents dans les maladies mitochondriales ?\nLes symptômes varient-ils selon l'âge d'apparition ?", "url": "https://questionsmedicales.fr/mesh/D024101?mesh_terms=Drug+Compounding&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Protéines mitochondriales", "description": "Peut-on prévenir les maladies mitochondriales ?\nL'exercice physique peut-il réduire les risques ?\nLes antioxydants jouent-ils un rôle préventif ?\nUne alimentation équilibrée est-elle importante ?\nLes dépistages précoces sont-ils recommandés ?", "url": "https://questionsmedicales.fr/mesh/D024101?mesh_terms=Drug+Compounding&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Protéines mitochondriales", "description": "Quels traitements sont disponibles pour les maladies mitochondriales ?\nLes coenzymes Q10 sont-elles bénéfiques ?\nLa thérapie génique est-elle une option pour ces maladies ?\nLes régimes alimentaires peuvent-ils aider ?\nLes traitements varient-ils selon le type de maladie mitochondriale ?", "url": "https://questionsmedicales.fr/mesh/D024101?mesh_terms=Drug+Compounding&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Protéines mitochondriales", "description": "Quelles complications peuvent survenir avec les maladies mitochondriales ?\nLes maladies mitochondriales peuvent-elles affecter la fertilité ?\nLes complications peuvent-elles être gérées ?\nLes maladies mitochondriales augmentent-elles le risque de cancer ?\nLes complications cardiovasculaires sont-elles fréquentes ?", "url": "https://questionsmedicales.fr/mesh/D024101?mesh_terms=Drug+Compounding&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Protéines mitochondriales", "description": "Quels sont les facteurs de risque pour les maladies mitochondriales ?\nL'âge est-il un facteur de risque ?\nLes facteurs environnementaux influencent-ils les maladies mitochondriales ?\nLe stress oxydatif est-il un facteur de risque ?\nLes habitudes alimentaires peuvent-elles influencer le risque ?", "url": "https://questionsmedicales.fr/mesh/D024101?mesh_terms=Drug+Compounding&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une dysfonction mitochondriale ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic peut inclure des tests génétiques, des biopsies musculaires et des analyses biochimiques." } }, { "@type": "Question", "name": "Quels tests sanguins sont utilisés pour évaluer les protéines mitochondriales ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de lactate, pyruvate et des enzymes spécifiques peuvent être effectués." } }, { "@type": "Question", "name": "Quels symptômes indiquent une maladie mitochondriale ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Fatigue, faiblesse musculaire, troubles neurologiques et problèmes cardiaques peuvent indiquer une maladie." } }, { "@type": "Question", "name": "Les tests génétiques sont-ils fiables pour les maladies mitochondriales ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les tests génétiques peuvent identifier des mutations spécifiques liées aux maladies mitochondriales." } }, { "@type": "Question", "name": "Quel rôle joue l'imagerie dans le diagnostic mitochondrial ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'imagerie par résonance magnétique (IRM) peut aider à visualiser des anomalies cérébrales." } }, { "@type": "Question", "name": "Quels sont les symptômes courants des maladies mitochondriales ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fatigue, douleurs musculaires, troubles de la vision et épilepsie." } }, { "@type": "Question", "name": "Les troubles cognitifs sont-ils liés aux protéines mitochondriales ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles cognitifs peuvent survenir en raison de dysfonctionnements mitochondriaux." } }, { "@type": "Question", "name": "Comment la myopathie mitochondriale se manifeste-t-elle ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elle se manifeste par une faiblesse musculaire, des crampes et une intolérance à l'exercice." } }, { "@type": "Question", "name": "Les troubles cardiaques sont-ils fréquents dans les maladies mitochondriales ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des cardiomyopathies peuvent se développer en raison de dysfonctionnements mitochondriaux." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'âge d'apparition ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier considérablement selon l'âge d'apparition de la maladie." } }, { "@type": "Question", "name": "Peut-on prévenir les maladies mitochondriales ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Certaines maladies génétiques ne peuvent pas être prévenues, mais un mode de vie sain aide." } }, { "@type": "Question", "name": "L'exercice physique peut-il réduire les risques ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut améliorer la santé mitochondriale et réduire les risques." } }, { "@type": "Question", "name": "Les antioxydants jouent-ils un rôle préventif ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les antioxydants peuvent protéger les mitochondries des dommages oxydatifs." } }, { "@type": "Question", "name": "Une alimentation équilibrée est-elle importante ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en nutriments soutient la santé mitochondriale." } }, { "@type": "Question", "name": "Les dépistages précoces sont-ils recommandés ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le dépistage précoce peut aider à identifier les risques et à intervenir rapidement." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les maladies mitochondriales ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des suppléments, des thérapies symptomatiques et des approches nutritionnelles." } }, { "@type": "Question", "name": "Les coenzymes Q10 sont-elles bénéfiques ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le coenzyme Q10 peut améliorer la fonction mitochondriale et réduire les symptômes." } }, { "@type": "Question", "name": "La thérapie génique est-elle une option pour ces maladies ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie génique est en recherche, mais elle pourrait offrir des solutions futures." } }, { "@type": "Question", "name": "Les régimes alimentaires peuvent-ils aider ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des régimes spécifiques peuvent soutenir la fonction mitochondriale et améliorer les symptômes." } }, { "@type": "Question", "name": "Les traitements varient-ils selon le type de maladie mitochondriale ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements doivent être adaptés au type spécifique de maladie mitochondriale." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec les maladies mitochondriales ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des troubles neurologiques, cardiaques et endocriniens." } }, { "@type": "Question", "name": "Les maladies mitochondriales peuvent-elles affecter la fertilité ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines maladies mitochondriales peuvent entraîner des problèmes de fertilité." } }, { "@type": "Question", "name": "Les complications peuvent-elles être gérées ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être gérées avec des traitements symptomatiques appropriés." } }, { "@type": "Question", "name": "Les maladies mitochondriales augmentent-elles le risque de cancer ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines études suggèrent un lien entre dysfonction mitochondriale et risque accru de cancer." } }, { "@type": "Question", "name": "Les complications cardiovasculaires sont-elles fréquentes ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les maladies mitochondriales peuvent entraîner des cardiomyopathies et d'autres complications." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les maladies mitochondriales ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, des mutations génétiques et des expositions environnementales." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines maladies mitochondriales se manifestent plus fréquemment avec l'âge." } }, { "@type": "Question", "name": "Les facteurs environnementaux influencent-ils les maladies mitochondriales ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des toxines peut augmenter le risque de dysfonction mitochondriale." } }, { "@type": "Question", "name": "Le stress oxydatif est-il un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress oxydatif peut endommager les mitochondries et contribuer à des maladies." } }, { "@type": "Question", "name": "Les habitudes alimentaires peuvent-elles influencer le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation pauvre en nutriments peut augmenter le risque de dysfonction mitochondriale." } } ] } ] }

Sous-catégories

25 au total
└─

Aldehyde dehydrogenase, mitochondrial

Aldehyde Dehydrogenase, Mitochondrial D000071396 - D12.776.575.093
└─

Mitochondrial creatine kinase

Creatine Kinase, Mitochondrial Form D052281 - D12.776.575.186
└─

DNA Polymerase gamma

DNA Polymerase gamma D000074002 - D12.776.575.280
└─

Ferrochelatase

Ferrochelatase D005294 - D12.776.575.562
└─

Protéines de transport de la membrane mitochondriale

Mitochondrial Membrane Transport Proteins D033681 - D12.776.575.750
└─

Protéine trifonctionnelle mitochondriale

Mitochondrial Trifunctional Protein D063991 - D12.776.575.765
└─

Nucleoside diphosphate kinase D

Nucleoside Diphosphate Kinase D D061107 - D12.776.575.781
└─

Peroxiredoxin III

Peroxiredoxin III D061105 - D12.776.575.812
└─

Prohibitines

Prohibitins D000091402 - D12.776.575.844
└─

Sirtuine-3

Sirtuin 3 D056566 - D12.776.575.875
└─└─

Mitochondrial ADP, ATP Translocases

Mitochondrial ADP, ATP Translocases D000226 - D12.776.575.750.500
└─└─

Pore de transition de perméabilité mitochondriale

Mitochondrial Permeability Transition Pore D000083162 - D12.776.575.750.563
└─└─

Protéines du complexe d'import des protéines précurseurs mitochondriales

Mitochondrial Precursor Protein Import Complex Proteins D000090622 - D12.776.575.750.594
└─└─

Mitochondrial Proton-Translocating ATPases

Mitochondrial Proton-Translocating ATPases D025261 - D12.776.575.750.625
└─└─

Protéines de découplage mitochondrial

Mitochondrial Uncoupling Proteins D000071245 - D12.776.575.750.688
└─└─

Canal anionique-1 voltage-dépendant

Voltage-Dependent Anion Channel 1 D050995 - D12.776.575.750.750
└─└─

Canal anionique-2 voltage-dépendant

Voltage-Dependent Anion Channel 2 D050996 - D12.776.575.750.875
└─└─

Sous-unité alpha de la protéine trifonctionnelle mitochondriale

Mitochondrial Trifunctional Protein, alpha Subunit D063992 - D12.776.575.765.200
└─└─

Sous-unité bêta de la protéine trifonctionnelle mitochondriale

Mitochondrial Trifunctional Protein, beta Subunit D063993 - D12.776.575.765.500
└─└─└─

Translocateur-1 de nucléotides adényliques

Adenine Nucleotide Translocator 1 D033741 - D12.776.575.750.500.100
└─└─└─

Translocateur-2 de nucléotides adényliques

Adenine Nucleotide Translocator 2 D033742 - D12.776.575.750.500.200
└─└─└─

Translocateur-3 de nucléotides adényliques

Adenine Nucleotide Translocator 3 D033781 - D12.776.575.750.500.300
└─└─└─

Protéine-1 de découplage

Uncoupling Protein 1 D000071256 - D12.776.575.750.688.500
└─└─└─

Protéine-2 de découplage

Uncoupling Protein 2 D000071246 - D12.776.575.750.688.750
└─└─└─

Protéine-3 de découplage

Uncoupling Protein 3 D000071247 - D12.776.575.750.688.875

Sources (10000 au total)

Compounded medications for cardiovascular use in neonatology: an integrative review.

To analyze the profile of the compounded cardiovascular medicines prescribed in neonatology in Brazil.... An integrative bibliographic review was carried out, including studies published in the last 20 years. The used descriptors were: Intensive Care Neonatal, Off-Label Use, Pharmaceutical Preparations, i... The profile of routine prescrption in the neonatal unit was evaluated. The main cardiovascular medications prescribed as compounding formulation were: Spironolactone, Captopril, Furosemide, Hydrochlor... It was possible to analyze the profile of compounded cardiovascular medicines prescribed in neonatology in Brazil. The results showed the need for the development of medications suitable for the neona...

Impact of Apparatus and Adapter on In vitro Drug Release of Ophthalmic Semisolid Drug Products.

In vitro release testing (IVRT) is a widely used tool for evaluating the quality and performance of drug products. However, standardized sample adaptors or drug release apparatus setups for IVRT studi... Dexamethasone (DEX), a steroidal ingredient commonly used in ophthalmic drug products, was selected as a model drug. Ointments were prepared by mixing DEX in white petrolatum using a high shear mixer.... The sample adaptor setups had a minimal impact on cumulative drug release amount per area or release rate while USP IV apparatus with agitated flow enhanced drug release rates. The USP apparatus I wit... USP apparatuses and sample adaptors are critical considerations for IVRT. Two-sided semisolid adapter provides higher cumulative release, facilitating the discrimination between low drug content ophth...

Economic Considerations and Cost-Saving Strategies for Nonsterile Compounding Education.

To determine the economic considerations, including cost-saving strategies, associated with nonsterile compounding education for students in schools and colleges of pharmacy across the United States.... An electronic survey was sent to the American Association of Colleges of Pharmacy Pharmaceutics Section and Laboratory Instructor's Special Interest Group members. Quantitative and qualitative data we... Of 555 surveys sent, 46 were completed. Reported annual compounding budgets ranged from $3000 to $96,000. Reported annual equipment maintenance costs ranged from $400 to $18,000. Fifty percent of resp... Findings from this study may assist pharmacy administrators and course directors in evaluating the costs associated with nonsterile compounding education across the Academy and, more importantly, dete...

Magistral Compounding with 3D Printing: A Promising Way to Achieve Personalized Medicine.

Magistral compounding has always been an integral part of pharmacy practice. The increasing demand worldwide for personalized drug treatments might be accommodated by an increase in magistral compound... To investigate how 3D printing can be integrated into the existing compounding system by taking regulatory, economic, and profession-oriented aspects into account.... Semi-structured interviews were conducted with relevant Dutch stakeholders representing various health institutions, such as health ministries and boards, professional bodies, and different types of p... A total of 15 Dutch stakeholders were interviewed. It was found that the prevalence of compounding in community pharmacies in the Netherlands has decreased as a result of the practice shifting to spec... In the Netherlands, specialized compounding pharmacies have largely taken over compounding activities. 3D printing could be introduced within this system; however, challenges regarding how to regulate...